Structural Basis for the Inhibition of RNase H Activity of HIV-1 Reverse Transcriptase by RNase H Active Site-Directed Inhibitors

HIV/AIDS continues to be a menace to public health. Several drugs currently on the market have successfully improved the ability to manage the viral burden in infected patients. However, new drugs are needed to combat the rapid emergence of mutated forms of the virus that are resistant to existing t...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Su, Hua-Poo, Yan, Youwei, Prasad, G. Sridhar, Smith, Robert F., Daniels, Christopher L., Abeywickrema, Pravien D., Reid, John C., Loughran, H. Marie, Kornienko, Maria, Sharma, Sujata, Grobler, Jay A., Xu, Bei, Sardana, Vinod, Allison, Timothy J., Williams, Peter D., Darke, Paul L., Hazuda, Daria J., Munshi, Sanjeev
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology (ASM) 2010
Sujets:
Vaccines and Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2897604/
https://ncbi.nlm.nih.gov/pubmed/20484498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00353-10
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires